نتائج البحث - B Charpentier

  • يعرض 1 - 11 نتائج من 11
تنقيح النتائج
  1. 1
    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study

    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study حسب Nassim Kamar, Valérie Garrigue, A. Karras, G. Mourad, N Lefrançois, B Charpentier, Christophe Legendre, Lionel Rostaing

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS

    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS حسب F. Vincenti, J. Grinyó, Christian P. Larsen, José Osmar Medina Pestana, Yves Vanrenterghem, Tao Duan, Mamta Agarwal, B Charpentier

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT)

    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT) حسب F. Vincenti, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Lionel Rostaing, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Christian P. Larsen

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY

    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY حسب Christian P. Larsen, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Nassim Kamar, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Pushkal Garg, F. Vincenti

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia حسب Maurizio Salvadori, Klemens Budde, B Charpentier, Jürgen Klempnauer, Björn Nashan, Luis Pallardó, Josette Eris, Francesco Paolo Schena, Ute Eisenberger, Lionel Rostaing, Abdel Hmissi, Shreeram Aradhye

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers

    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents a... حسب A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein

    منشور في 1993
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials

    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials حسب Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, G. Mondragon-Ramirez, Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, S Schleibner, Nassim Kamar

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study حسب Rachel Hellemans, Marc Hazzan, D. Durand, G. Mourad, P Lang, Martin Kessler, B Charpentier, Guy Touchard, F. Berthoux, Pierre Merville, Nacéra Ouali, J.P. Squifflet, François Bayle, Karl Martin Wissing, C. Noël, Daniel Abramowicz

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients حسب Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcı́a, J. Kothari, Philippe Lang, Eduardo Mancilla Urrea, P. Massari, G. Mondragon-Ramirez, Rafael Reyes‐Acevedo, Kim Rice, Lionel Rostaing, S. Steinberg, J. Xing, Mamta Agarwal, M. Harler, B Charpentier

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Rand... حسب Philippe Gatault, Nassim Kamar, M. Büchler, Claudio Colosio, Dominique Bertrand, Antoine Dürrbach, Laetitia Albano, J Rivalan, Yannick Le Meur, Marie Essig, Nicolas Bouvier, Christophe Legendre, Bruno Moulin, A.E. Heng, P.-F. Weestel, Johnny Sayegh, B Charpentier, Lionel Rostaing, Éric Thervet, Yvon Lebranchu

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice حسب Paula M. Chilton, Smita Ghare, B Charpentier, S Myers, Aakarsha V. Rao, Joseph F. Petrosino, Kristi L. Hoffman, John C. Greenwell, Neetu Tyagi, Jyotirmaya Behera, Yali Wang, Lucy Sloan, JingWen Zhang, Christopher Shields, Gregory E. Cooper, Leila Gobejishvili, Scott R. Whittemore, Craig J. McClain, Shirish Barve

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: